WG2. Functional Biology

Leadership

Chris Lord
Chris Lord

ICR LONDON

Patrick Derksen
Patrick Derksen

UMC UTRECHT

Clair Turner
Clair Turner

PA (UK), LBCUK

Participants

Beatrice Howard Institute of Cancer Research
Cathrin Brisken EPFL/ICR
Christopher Lord Institute of Cancer Research
Christine Desmedt KU Leuven
Claire Turner Lobular Breast Cancer UK
David Spector CSHL
George Sflomos EPFL
Georgios Skiadas Institute of Cancer Research
Minakshi Gandhi CSHL
Patrick Derksen UMC Utrecht
Renee Flaherty Institute of Cancer Research
Sankari Nagarajan The University of Manchester
Santiago Madera Institute of Cancer Research
Syed Haider Institute of Cancer Research
Thurkaa Shanmugalingam King’s College London
Val Brunton Edinburgh Cancer Centre
William Yang ICR
Yanbo Liu Institute of Cancer Research

 

 

Past and Future meetings

START-UP NEW FB WG (Online, Feb 24rd, 2025)

Leadership meeting to mark the start of the new WG “functional Biology”

MODELS MEETING (Utrecht, October 12-13, 2023)

Strategic Alignment meeting @ UMC Utrecht.

Activities

The Functional Biology Working Groups (formerly the Models WG) represents a close-nit group that has been productive from the start of the ELBCC in 2018. They have  published a seminar paper, a Tour de Force first-authored by Georgios Flomos (EFPL) in which the current state of affairs were culminated in the ATLAS OF LOBULAR BREAST CANCER MODELS
Click on the image to download the paper as PDF.

Members from the UMC Utrecht (Derksen lab) have published a paper in THE JOURNAL OF PATHOLOGY showing that Afadin (AFDN), represents a new ILC invasion suppressor. They show that Afadin confers invasion suppression through stabilization of the E-cadherin to F-actin link through the  α-catenin binding CC domain.